PortfoliosLab logoPortfoliosLab logo
ESPR vs. ZIM
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

ESPR vs. ZIM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Esperion Therapeutics, Inc. (ESPR) and ZIM Integrated Shipping Services Ltd. (ZIM). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

ESPR vs. ZIM - Yearly Performance Comparison


2026 (YTD)20252024202320222021
ESPR
Esperion Therapeutics, Inc.
-25.95%68.18%-26.42%-52.01%24.60%-84.43%
ZIM
ZIM Integrated Shipping Services Ltd.
28.30%28.11%176.93%-21.06%-52.70%463.11%

Fundamentals

Market Cap

ESPR:

$779.73M

ZIM:

$3.18B

EPS

ESPR:

-$0.10

ZIM:

$3.98

PS Ratio

ESPR:

1.54

ZIM:

0.46

Total Revenue (TTM)

ESPR:

$403.14M

ZIM:

$6.90B

Gross Profit (TTM)

ESPR:

$119.19M

ZIM:

$1.16B

EBITDA (TTM)

ESPR:

$62.77M

ZIM:

$2.27B

Returns By Period

In the year-to-date period, ESPR achieves a -25.95% return, which is significantly lower than ZIM's 28.30% return.


ESPR

1D
4.18%
1M
-18.21%
YTD
-25.95%
6M
3.40%
1Y
90.28%
3Y*
19.89%
5Y*
-37.49%
10Y*
-16.92%

ZIM

1D
1.82%
1M
-5.52%
YTD
28.30%
6M
104.13%
1Y
98.85%
3Y*
37.85%
5Y*
32.97%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ESPR vs. ZIM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ESPR
ESPR Risk / Return Rank: 7474
Overall Rank
ESPR Sharpe Ratio Rank: 7777
Sharpe Ratio Rank
ESPR Sortino Ratio Rank: 7676
Sortino Ratio Rank
ESPR Omega Ratio Rank: 7171
Omega Ratio Rank
ESPR Calmar Ratio Rank: 7474
Calmar Ratio Rank
ESPR Martin Ratio Rank: 7272
Martin Ratio Rank

ZIM
ZIM Risk / Return Rank: 8484
Overall Rank
ZIM Sharpe Ratio Rank: 8686
Sharpe Ratio Rank
ZIM Sortino Ratio Rank: 8686
Sortino Ratio Rank
ZIM Omega Ratio Rank: 8383
Omega Ratio Rank
ZIM Calmar Ratio Rank: 8484
Calmar Ratio Rank
ZIM Martin Ratio Rank: 8181
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ESPR vs. ZIM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Esperion Therapeutics, Inc. (ESPR) and ZIM Integrated Shipping Services Ltd. (ZIM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ESPRZIMDifference

Sharpe ratio

Return per unit of total volatility

1.09

1.57

-0.48

Sortino ratio

Return per unit of downside risk

1.85

2.42

-0.57

Omega ratio

Gain probability vs. loss probability

1.22

1.30

-0.09

Calmar ratio

Return relative to maximum drawdown

1.68

2.68

-1.00

Martin ratio

Return relative to average drawdown

3.82

6.03

-2.21

ESPR vs. ZIM - Sharpe Ratio Comparison

The current ESPR Sharpe Ratio is 1.09, which is lower than the ZIM Sharpe Ratio of 1.57. The chart below compares the historical Sharpe Ratios of ESPR and ZIM, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


ESPRZIMDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.09

1.57

-0.48

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.42

0.49

-0.91

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.20

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.15

0.80

-0.95

Correlation

The correlation between ESPR and ZIM is 0.11, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

ESPR vs. ZIM - Dividend Comparison

ESPR has not paid dividends to shareholders, while ZIM's dividend yield for the trailing twelve months is around 7.55%.


TTM20252024202320222021
ESPR
Esperion Therapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%
ZIM
ZIM Integrated Shipping Services Ltd.
7.55%20.16%22.40%64.84%160.27%7.65%

Drawdowns

ESPR vs. ZIM - Drawdown Comparison

The maximum ESPR drawdown since its inception was -99.37%, which is greater than ZIM's maximum drawdown of -84.68%. Use the drawdown chart below to compare losses from any high point for ESPR and ZIM.


Loading graphics...

Drawdown Indicators


ESPRZIMDifference

Max Drawdown

Largest peak-to-trough decline

-99.37%

-84.68%

-14.69%

Max Drawdown (1Y)

Largest decline over 1 year

-48.23%

-32.64%

-15.59%

Max Drawdown (5Y)

Largest decline over 5 years

-97.46%

-84.68%

-12.78%

Max Drawdown (10Y)

Largest decline over 10 years

-99.10%

Current Drawdown

Current decline from peak

-97.62%

-6.94%

-90.68%

Average Drawdown

Average peak-to-trough decline

-69.54%

-41.12%

-28.42%

Ulcer Index

Depth and duration of drawdowns from previous peaks

21.62%

14.49%

+7.13%

Volatility

ESPR vs. ZIM - Volatility Comparison

Esperion Therapeutics, Inc. (ESPR) has a higher volatility of 27.56% compared to ZIM Integrated Shipping Services Ltd. (ZIM) at 9.55%. This indicates that ESPR's price experiences larger fluctuations and is considered to be riskier than ZIM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


ESPRZIMDifference

Volatility (1M)

Calculated over the trailing 1-month period

27.56%

9.55%

+18.01%

Volatility (6M)

Calculated over the trailing 6-month period

57.36%

40.45%

+16.91%

Volatility (1Y)

Calculated over the trailing 1-year period

83.33%

63.53%

+19.80%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

89.13%

67.47%

+21.66%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

83.10%

68.52%

+14.58%

Financials

ESPR vs. ZIM - Financials Comparison

This section allows you to compare key financial metrics between Esperion Therapeutics, Inc. and ZIM Integrated Shipping Services Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00BAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
168.45M
1.48B
(ESPR) Total Revenue
(ZIM) Total Revenue
Values in USD except per share items

ESPR vs. ZIM - Profitability Comparison

The chart below illustrates the profitability comparison between Esperion Therapeutics, Inc. and ZIM Integrated Shipping Services Ltd. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

-20.0%0.0%20.0%40.0%60.0%80.0%100.0%AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober0
5.6%
Portfolio components
ESPR - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Esperion Therapeutics, Inc. reported a gross profit of 0.00 and revenue of 168.45M. Therefore, the gross margin over that period was 0.0%.

ZIM - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, ZIM Integrated Shipping Services Ltd. reported a gross profit of 83.60M and revenue of 1.48B. Therefore, the gross margin over that period was 5.6%.

ESPR - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Esperion Therapeutics, Inc. reported an operating income of 85.23M and revenue of 168.45M, resulting in an operating margin of 50.6%.

ZIM - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, ZIM Integrated Shipping Services Ltd. reported an operating income of 3.20M and revenue of 1.48B, resulting in an operating margin of 0.2%.

ESPR - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Esperion Therapeutics, Inc. reported a net income of 61.83M and revenue of 168.45M, resulting in a net margin of 36.7%.

ZIM - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, ZIM Integrated Shipping Services Ltd. reported a net income of 38.10M and revenue of 1.48B, resulting in a net margin of 2.6%.